Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kura Oncology, Inc. | 173,614 | reported | 21 May 2026 | tx 16+631,550−36,114 |
| FATE THERAPEUTICS INC | 41,146 | reported | 05 Jul 2023 | tx 4+540,000−3,854 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | SALE | Kura Oncology, Inc. | 10,000 | 11.00 USD | 10b5-1 |
| 19 May 2026 | SALE | Kura Oncology, Inc. | 339 | 9.21 USD | 10b5-1 |
| 27 Jan 2026 | SALE | Kura Oncology, Inc. | 1,572 | 8.46 USD | |
| 27 Jan 2026 | SALE | Kura Oncology, Inc. | 4,842 | 8.46 USD | |
| 02 Jan 2026 | GRANT_AWARD | Kura Oncology, Inc. | 50,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Kura Oncology, Inc. | 100,000 | 0.00 USD | deriv |
| 14 Nov 2025 | SALE | Kura Oncology, Inc. | 8,887 | 11.18 USD | |
| 13 Nov 2025 | GRANT_AWARD | Kura Oncology, Inc. | 48,900 | 0.00 USD | |
| 29 Sept 2025 | SALE | Kura Oncology, Inc. | 8,891 | 8.94 USD | |
| 27 Sept 2025 | GRANT_AWARD | Kura Oncology, Inc. | 48,900 | 0.00 USD | |
| 28 Jan 2025 | SALE | Kura Oncology, Inc. | 1,583 | 7.87 USD | |
| 02 Jan 2025 | GRANT_AWARD | Kura Oncology, Inc. | 46,250 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Kura Oncology, Inc. | 92,500 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Kura Oncology, Inc. | 15,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Kura Oncology, Inc. | 30,000 | 0.00 USD | deriv |
| 14 Aug 2023 | GRANT_AWARD | Kura Oncology, Inc. | 200,000 | 0.00 USD | deriv |
| 05 Jul 2023 | SALE | FATE THERAPEUTICS INC | 3,854 | 4.87 USD | |
| 06 Feb 2023 | GRANT_AWARD | FATE THERAPEUTICS INC | 425,000 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | FATE THERAPEUTICS INC | 45,000 | 0.00 USD | |
| 27 Jun 2022 | GRANT_AWARD | FATE THERAPEUTICS INC | 70,000 | 0.00 USD | deriv |